Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00103181 · ClinicalTrials.gov registry record · NA
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
A NA study of Breast Cancer, sponsored by NSABP Foundation.
- Completed
- Registry status
- NA
- Development phase
- 4,216
- Enrollment target
- 20
- Study locations
NCT00103181: Completed NA study of Breast Cancer, sponsored by NSABP Foundation.
NCT00103181 is a NA study of Breast Cancer that has completed, run by NSABP Foundation. The registered enrollment target is 4,216 participants, above the 2,800-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (51% higher). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00103181, a NA study of Breast Cancer, has completed, sponsored by NSABP Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,216 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy in different ways may kill any tumor cells that remain after surgery. It is not yet known whether whole breast radiation therapy is more effective than partial breast radiation therapy in treating breast cancer. PURPOSE: This randomized phase III trial is studying whole breast radiation therapy to see how well it works compared to partial breast radiation therapy in treating women who have undergone surgery for ductal carcinoma in situ or stage I or stage II breast cancer.
Conditions Studied
Interventions
- RADIATION brachytherapy
- RADIATION whole breast irradiation
- RADIATION 3-dimensional conformal accelerated partial breast irradiation
- RADIATION MammoSite or other single-entry intracavitary device
Study Locations (20)
California
- Auburn Radiation Oncology - Auburn
- Alta Bates Summit Comprehensive Cancer Center - Berkeley
- Peninsula Medical Center - Burlingame
- Radiation Oncology Centers - Cameron Park - Cameron Park
- Mercy Cancer Center at Mercy San Juan Medical Center - Carmichael
- Enloe Cancer Center at Enloe Medical Center - Chico
- Cancer Care Center at John Muir Health - Concord Campus - Concord
- City of Hope Comprehensive Cancer Center - Duarte
- North Bay Cancer Center - Fairfield
- California Cancer Center - Woodward Park Office - Fresno
- Kaiser Permanente Medical Center - Hayward - Hayward
- Rebecca and John Moores UCSD Cancer Center - La Jolla
- Jonsson Comprehensive Cancer Center at UCLA - Los Angeles
- Community Hospital of the Monterey Peninsula Comprehensive Cancer Center - Monterey
Arizona
- Arizona Center for Cancer Care - Peoria - Peoria
- Arizona Oncology Services Foundation - Phoenix
- Arizona Breast Cancer Specialists - Scottsdale
- Mayo Clinic Scottsdale - Scottsdale
Alabama
- UAB Comprehensive Cancer Center - Birmingham
Arkansas
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,216 participants |
| Start Date | 2005-03 |
| Est. Completion | 2018-08 |
| Phase | NA |
What the finished NCT00103181 record still lists
NCT00103181 is an interventional study that assigns participants to a tested intervention. Its 4,216 participants enrollment target places it among the larger protocols in the corpus, above the 2,800-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (51% higher).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which brachytherapy is the first listed.
NCT00103181 names 20 study sites across 4 states, led by California, Arizona, Alabama.
Frequently Asked Questions
What is clinical trial NCT00103181 about?
NCT00103181 is a clinical study titled "Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy in different ways may kill any tumor cells that remain after surgery. It is not yet known whether whole breast radiation therapy is more effective than partial breast radiation therapy in treating brea...
What is the current status of trial NCT00103181?
This trial is currently completed. It is a NA study. The enrollment target is 4,216 participants. The study started on 2005-03. Estimated completion is 2018-08.
What conditions does trial NCT00103181 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT00103181?
The interventions under investigation include: brachytherapy (RADIATION), whole breast irradiation (RADIATION), 3-dimensional conformal accelerated partial breast irradiation (RADIATION), MammoSite or other single-entry intracavitary device (RADIATION).
Who is sponsoring clinical trial NCT00103181?
This trial is sponsored by NSABP Foundation, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00103181 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00103181's enrollment target sits among peer trials
4,216 34th of 1224 higher than 1,191 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT06935370 · 4,200 participants · Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- NCT07209098 · 4,200 participants
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia